Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions, Kidney International, vol.40, issue.2, pp.195-202, 1991. ,
DOI : 10.1038/ki.1991.200
Discoidin Domain Receptor 1 Null Mice Are Protected against Hypertension-Induced Renal Disease, Journal of the American Society of Nephrology, vol.17, issue.12, pp.3374-3381, 2006. ,
DOI : 10.1681/ASN.2006060677
Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration ,
Role of Matrix Metalloproteinases in Early Hypertensive Vascular Remodeling, Hypertension, vol.50, issue.1, pp.212-218, 2007. ,
DOI : 10.1161/HYPERTENSIONAHA.107.089631
Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin., Journal of Clinical Investigation, vol.101, issue.12, pp.2780-2789, 1998. ,
DOI : 10.1172/JCI2132
Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism, AJP: Renal Physiology, vol.297, issue.1, pp.191-199, 2009. ,
DOI : 10.1152/ajprenal.00015.2009
Regression of Renal Vascular and Glomerular Fibrosis: Role of Angiotensin II Receptor Antagonism and Matrix Metalloproteinases, Journal of the American Society of Nephrology, vol.14, issue.5, pp.1132-1144, 2003. ,
DOI : 10.1097/01.ASN.0000060574.38107.3B
Restoration of Podocyte Structure and Improvement of Chronic Renal Disease in Transgenic Mice Overexpressing Renin, PLoS ONE, vol.23, issue.8, p.6721, 2009. ,
DOI : 10.1371/journal.pone.0006721.t001
Reversal of Glomerulosclerosis after High-Dose Enalapril Treatment in Subtotally Nephrectomized Rats, Journal of the American Society of Nephrology, vol.14, issue.11, pp.2833-2842, 2003. ,
DOI : 10.1097/01.ASN.0000095248.91994.D3
Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination, AJP: Renal Physiology, vol.295, issue.1, pp.137-144, 2008. ,
DOI : 10.1152/ajprenal.00065.2008
Pathological Regression by Angiotensin II Type 1 Receptor Blockade in Patients with Mesangial Proliferative Glomerulonephritis, Hypertension Research, vol.31, issue.3, pp.387-394, 2008. ,
DOI : 10.1291/hypres.31.387
Regeneration and the kidney, Current Opinion in Nephrology and Hypertension, vol.19, issue.3, pp.248-253, 2010. ,
DOI : 10.1097/MNH.0b013e32833680dc
CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice, Journal of Clinical Investigation, vol.119, issue.8, pp.2330-2334, 2009. ,
DOI : 10.1172/JCI39087DS1
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy, Kidney International, vol.75, issue.11, pp.1145-1152, 2009. ,
DOI : 10.1038/ki.2009.86
Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats, AJP: Renal Physiology, vol.287, issue.6, pp.1283-1293, 2004. ,
DOI : 10.1152/ajprenal.00441.2003
Recovery from release of ureteral obstruction in the rat: Relationship to nephrogenesis, Kidney International, vol.61, issue.6, pp.2033-2043, 2002. ,
DOI : 10.1046/j.1523-1755.2002.00359.x
Enalapril accelerates remodeling of the renal interstitium after release of unilateral ureteral obstruction in rats, J Nephrol, vol.16, pp.203-209, 2003. ,
Renal Structural and Functional Repair in a Mouse Model of Reversal of Ureteral Obstruction, Journal of the American Society of Nephrology, vol.16, issue.12, pp.3623-3623, 2005. ,
DOI : 10.1681/ASN.2004090771
Thrombospondin-1 Is a Major Activator of TGF-??1 In Vivo, Cell, vol.93, issue.7, pp.1159-1170, 1998. ,
DOI : 10.1016/S0092-8674(00)81460-9
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies, Nature Reviews Cancer, vol.14, issue.3, pp.182-194, 2009. ,
DOI : 10.1038/nrc2561
Thrombospondins: from structure to therapeutics, Cellular and Molecular Life Sciences, vol.65, issue.5, pp.672-686, 2008. ,
DOI : 10.1007/s00018-007-7484-1
Epithelial-mesenchymal transition and its implications for fibrosis, Journal of Clinical Investigation, vol.112, issue.12, pp.1776-1784, 2003. ,
DOI : 10.1172/JCI200320530
Reimplantation of the ureter after unilateral ureteral obstruction provides a model that allows functional evaluation, Kidney International, vol.73, issue.7, pp.885-889, 2008. ,
DOI : 10.1038/sj.ki.5002797
Chronic kidney disease induced in mice by reversible unilateral ureteral obstruction is dependent on genetic background, AJP: Renal Physiology, vol.298, issue.4, pp.1024-1032, 2010. ,
DOI : 10.1152/ajprenal.00384.2009
Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis, Journal of the American Society of Nephrology, vol.15, issue.4, pp.940-948, 2004. ,
DOI : 10.1097/01.ASN.0000120371.09769.80
Macrophage Phenotype and Renal Fibrosis in Obstructive Nephropathy, Nephron Experimental Nephrology, vol.110, issue.1, pp.31-36, 2008. ,
DOI : 10.1159/000151561
Macrophage diversity in renal injury and repair, Journal of Clinical Investigation, vol.118, issue.11, pp.3522-3530, 2008. ,
DOI : 10.1172/JCI36150
Macrophage Wnt7b is critical for kidney repair and regeneration, Proceedings of the National Academy of Sciences, vol.107, issue.9, pp.4194-4199, 2010. ,
DOI : 10.1073/pnas.0912228107
Targeted disruption of TGF-??1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction, Journal of Clinical Investigation, vol.112, issue.10, pp.1486-1494, 2003. ,
DOI : 10.1172/JCI200319270
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity, Cytokine & Growth Factor Reviews, vol.8, issue.1, pp.21-43, 1997. ,
DOI : 10.1016/S1359-6101(96)00048-2
Latent Transforming Growth Factor-?? Binding Protein Domains Involved in Activation and Transglutaminase-dependent Cross-Linking of Latent Transforming Growth Factor-??, The Journal of Cell Biology, vol.267, issue.5, pp.1151-1163, 1997. ,
DOI : 10.1083/jcb.124.5.855
Transforming Growth Factor-??-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in ??6???/??? Mice, The American Journal of Pathology, vol.163, issue.4, pp.1261-1273, 2003. ,
DOI : 10.1016/S0002-9440(10)63486-4
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1, J Am Soc Nephrol, vol.12, pp.1434-1447, 2001. ,
Thrombospondin-1 Is an Endogenous Activator of TGF-?? in Experimental Diabetic Nephropathy In Vivo, Diabetes, vol.56, issue.12, pp.2982-2989, 2007. ,
DOI : 10.2337/db07-0551
Correlation of enhanced thrombospondin-1 expression, TGF-?? signalling and proteinuria in human type-2 diabetic nephropathy, Nephrology Dialysis Transplantation, vol.23, issue.12, pp.3880-3887, 2008. ,
DOI : 10.1093/ndt/gfn399
Thrombospondin-based antiangiogenic therapy, Microvascular Research, vol.74, issue.2-3, pp.90-99, 2007. ,
DOI : 10.1016/j.mvr.2007.04.007
Upregulated Expression of Transforming Growth Factor-.BETA., Type IV Collagen, and Plasminogen Activator Inhibitor-1 mRNA Are Decreased after Release of Unilateral Ureteral Obstruction., The Tohoku Journal of Experimental Medicine, vol.197, issue.3, pp.159-168, 2002. ,
DOI : 10.1620/tjem.197.159
Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia., Journal of Clinical Investigation, vol.101, issue.5, pp.982-992, 1998. ,
DOI : 10.1172/JCI1684
Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and Thrombospondin-1 in renal disease, American Journal of Kidney Diseases, vol.37, issue.3, pp.601-611, 2001. ,
DOI : 10.1053/ajkd.2001.22087
Thrombospondin-1 is a major activator of TGF-?? in fibrotic renal disease in the rat in vivo, Kidney International, vol.65, issue.2, pp.459-468, 2004. ,
DOI : 10.1111/j.1523-1755.2004.00395.x
Antisense Oligonucleotides Against Thrombospondin-1 Inhibit Activation of TGF-?? in Fibrotic Renal Disease in the Rat in Vivo, The American Journal of Pathology, vol.163, issue.3, pp.1185-1192, 2003. ,
DOI : 10.1016/S0002-9440(10)63478-5
Role of Thrombospondin-1 in the Autologous Phase of an Accelerated Model of Anti-Glomerular Basement Membrane Glomerulonephritis, Nephron Experimental Nephrology, vol.96, issue.2, pp.31-38, 2004. ,
DOI : 10.1159/000076402
Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia, Journal of Clinical Investigation, vol.116, issue.2, pp.3451-3459, 2005. ,
DOI : 10.1172/JCI25461C1
Thrombospondin/CD47 Interaction: A Pathway to Generate Regulatory T Cells from Human CD4+CD25- T Cells in Response to Inflammation, The Journal of Immunology, vol.177, issue.6, pp.3534-3541, 2006. ,
DOI : 10.4049/jimmunol.177.6.3534
Interleukin-17 and Type 17 Helper T Cells, New England Journal of Medicine, vol.361, issue.9, pp.888-898, 2009. ,
DOI : 10.1056/NEJMra0707449
The Lack of Thrombospondin-1 (TSP1) Dictates the Course of Wound Healing in Double-TSP1/TSP2-Null Mice, The American Journal of Pathology, vol.161, issue.3 ,
DOI : 10.1016/S0002-9440(10)64243-5
The IL-23/Th17 Axis Contributes to Renal Injury in Experimental Glomerulonephritis, Journal of the American Society of Nephrology, vol.20, issue.5, pp.969-979, 2009. ,
DOI : 10.1681/ASN.2008050556
Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis, Journal of Autoimmunity, vol.32, issue.2, pp.94-103, 2009. ,
DOI : 10.1016/j.jaut.2008.12.004
Angiotensin II sustains brain inflammation in mice via TGF-??, Journal of Clinical Investigation, vol.120, issue.8, pp.2782-2794, 2010. ,
DOI : 10.1172/JCI41709DS1
Viability testing of homograft valves using methyl thiazol tetrazolium assay, J Postgrad Med, vol.42, pp.72-75, 1996. ,
A noninvasive murine model of hind limb ischemia-reperfusion injury, Journal of Surgical Research, vol.116, issue.1, pp.55-63, 2004. ,
DOI : 10.1016/S0022-4804(03)00232-4